The CDC currently estimates that nearly 1 in 5 children have a developmental or psychiatric disorder; yet evidence-based, targeted treatments for these disorders are lacking.
Taking an Experimental Therapeutics approach, the research that will be discussed aims to understand the mechanisms that contribute to dysfunctional development of neural systems associated with symptoms of pediatric psychiatric and neurodevelopmental disorders utilizing neuroimaging and neurophysiological tools combined with transcranial magnetic stimulation interventions. The ultimate goal of the research that will be discussed is to inform the development of novel targeted device-based treatment strategies. Though there is much promise for these targeted device-based interventions, data on the safety and efficacy of these interventions in pediatric and neurodevelopmental populations is limited. The current state of the research will be reviewed and future directions for the field will be discussed.
At the end of this presentation participants will be able to:
- Review the findings of studies using TMS to probe physiology in autism spectrum disorder (ASD).
- Describe how TMS can be used to induce long-term changes in brain network functioning and potentially treat pediatric neuropsychiatric and behavioral disorders.
- Identify potential network targets where applying TMS may be effective for reducing transdiagnostic symptom domains commonly seen in neuropsychiatric and behavioral disorders.
1 Hour CME Credit Available
Format: Live Webinar
Cost: Members: $25 | Non-members $50 | Student Members FREE
Speaker: Lindsay Oberman, PhD
Dr. Lindsay Oberman received her PhD from UCSD in Experimental Psychology in 2007. Since that time, she has published over 60 peer-reviewed articles. She has gained international attention for pioneering the use of Repetitive Transcranial Magnetic Stimulation (rTMS) in complex neurodevelopmental and neuropsychiatric disorders including autism, mood disorders, and traumatic brain injury. Dr. Oberman’s research involves the use of an experimental therapeutics approach applying neuroimaging and neurophysiological measures to identify dysfunctional neural circuitry associated with specific transdiagnostic behavioral domains such as mood regulation, sensory processing, social cognition, and executive functioning across disorders. In doing so, she is able to develop novel individualized rTMS treatment protocols that are informed by functional brain network organization. She is currently a Staff Scientist and Directs the Developmental Clinical Neurophysiology and Neurostimulation Research Program within the National Institute of Mental Health Intramural Research Program.